Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bertz

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effectsR J Bertz, P D Kroboth, F J Kroboth, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2004
Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 inductionMichael L Lim, Sherene S Min, Joseph J Eron, et al.
Clinical Pharmacology and Therapeutics|June 6, 2008
The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probeD M Burger, A Huisman, N Van Ewijk, et al.
Cancer|May 15, 1995
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patientsC Garbe, P Büttner, J Bertz, et al.
Cancer|May 15, 1995
Primary cutaneous melanoma. Prognostic classification of anatomic locationC Garbe, P Büttner, J Bertz, et al.
Antiviral Therapy|April 8, 2014
The effect of hepatic impairment on the pharmacokinetics of asunaprevir, an HCV NS3 protease inhibitorTimothy Eley, Bing He, Ih Chang, et al.
Cancer|May 15, 1995
Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classificationP Büttner, C Garbe, J Bertz, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1990
[Risk factors for the development of malignant melanoma in West Germany. Results of a multicenter-case control study]J Weiss, C Garbe, J Bertz, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
The German melanoma registry and environmental risk factors impliedC Garbe, J Weiss, S Krüger, et al.
Pharmacogenetics|April 30, 2004
Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokineticsKatherine D Furman, David R Grimm, Toby Mueller, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effectsR J Bertz, P D Kroboth, F J Kroboth, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2004
Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 inductionMichael L Lim, Sherene S Min, Joseph J Eron, et al.
Clinical Pharmacology and Therapeutics|June 6, 2008
The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probeD M Burger, A Huisman, N Van Ewijk, et al.
Cancer|May 15, 1995
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patientsC Garbe, P Büttner, J Bertz, et al.
Cancer|May 15, 1995
Primary cutaneous melanoma. Prognostic classification of anatomic locationC Garbe, P Büttner, J Bertz, et al.
Antiviral Therapy|April 8, 2014
The effect of hepatic impairment on the pharmacokinetics of asunaprevir, an HCV NS3 protease inhibitorTimothy Eley, Bing He, Ih Chang, et al.
Cancer|May 15, 1995
Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classificationP Büttner, C Garbe, J Bertz, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1990
[Risk factors for the development of malignant melanoma in West Germany. Results of a multicenter-case control study]J Weiss, C Garbe, J Bertz, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
The German melanoma registry and environmental risk factors impliedC Garbe, J Weiss, S Krüger, et al.
Pharmacogenetics|April 30, 2004
Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokineticsKatherine D Furman, David R Grimm, Toby Mueller, et al.
Pageof 6